Skip to content
Back to search
This tender has expired.

Hungary – Various medicinal products – Új, tételes elszámolású hatóanyagok beszerzése

Nemzeti Egészségbiztosítási AlapkezelőHungaryPublished on Jul 21, 2026
Deadline passed

Description

The procurement of active substances subject to accounting, within the framework of an open procedure according to point a) of paragraph 1 of Article 105 of the Public Procurement Act, with the possibility of extending the active period of the Framework Agreement.

Subject of the current procurement procedure (in parts):

1. Part: Dupilumab for children (OENO: 06126)

Base quantity: 715 200 mg

Optional quantity: 238 400 mg

Minimum mandatory product discount quantity with respect to the base quantity: 1 200 mg

Minimum mandatory product discount quantity with respect to the optional quantity: 400 mg

2. Part: Dupilumab for adults (OENO: 06126)

Base quantity: 23 493 600 mg

Optional quantity: 7 831 200 mg

Minimum mandatory product discount quantity with respect to the base quantity: 1 800 mg

Minimum mandatory product discount quantity with respect to the optional quantity: 600 mg

3. Part: Mirikizumab (OENO: 06101)

Base quantity: 1 009 800 mg

Optional quantity: 336 600 mg

Minimum mandatory product discount quantity with respect to the base quantity: 600 mg

Minimum mandatory product discount quantity with respect to the optional quantity: 200 mg

4. Part: Pirtobrutinib (OENO: 06123)

Base quantity: 5 930 400 mg

Optional quantity: 1 976 800 mg

Minimum mandatory product discount quantity with respect to the base quantity: 8 400 mg

Minimum mandatory product discount quantity with respect to the optional quantity: 2 800 mg

5. Part: Blinatumomab (OENO: 06106)

Base quantity: 4 320 amp

Optional quantity: 1 440 amp

Minimum mandatory product discount quantity with respect to the base quantity: 3 amp

Minimum mandatory product discount quantity with respect to the optional quantity: 1 amp

6. Part: Serplulimab (OENO: 06118)

Base quantity: 195 000 mg

Optional quantity: 65 000 mg

Minimum mandatory product discount quantity with respect to the base quantity: 300 mg

Minimum mandatory product discount quantity with respect to the optional quantity: 100 mg

The contracting authority draws the attention of economic operators to the fact that in each part, pursuant to point j) of paragraph 1 of Article 73 of the Public Procurement Act, any tender containing a higher total tender price than the net wholesale price of the lowest-priced medicinal product containing the given active substance, offered by the tenderer in the given part, listed in the PUPHA register on the date of the tender, multiplied by the mg (in the case of the 5th part, ampoule) unit price and the total framework quantity, is invalid.

CPV codes

Various medicinal products

Documents & submission

AI summary
Sign in for an AI summary

Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.

Related tenders